FDA reports manufacturing problems at Amylin's Ohio facility

03/14/2010 | Reuters

The FDA said it found several manufacturing problems at Amylin Pharmaceuticals' facility in West Chester, Ohio, during a December inspection. "We've addressed these findings in previous public statements, indicating that we believe these observations are addressable," said a spokeswoman for Amylin. The agency was scheduled to decide by Friday whether to approve a once-weekly formulation of Byetta, a Type 2 diabetes drug developed by Amylin and Eli Lilly and Co.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC
Sr Product Manager Global Marketing (US/DA/00/0085/SL) - 14000009V3
Abbott
Chicago, IL
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Director of Medicare Products
Bluegrass Family Health
Lexington, KY
Vice President, Information Technology
HealthPartners
MN